Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis.
- DOI
- 10.3389/fbioe.2018.00177
- Published
- 2018
- Container
- Frontiers in bioengineering and biotechnology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fbioe.2018.00177,
title = {Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis.},
author = {Cervadoro A and Palomba R and Vergaro G and Cecchi R and Menichetti L and Decuzzi P and Emdin M and Luin S},
year = {2018},
journal = {Frontiers in bioengineering and biotechnology},
doi = {10.3389/fbioe.2018.00177},
url = {https://doi.org/10.3389/fbioe.2018.00177}
}RIS
TY - JOUR TI - Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis. AU - Cervadoro A AU - Palomba R AU - Vergaro G AU - Cecchi R AU - Menichetti L AU - Decuzzi P AU - Emdin M AU - Luin S PY - 2018 JO - Frontiers in bioengineering and biotechnology DO - 10.3389/fbioe.2018.00177 UR - https://doi.org/10.3389/fbioe.2018.00177 ER -
APA
A, C., R, P., G, V., R, C., L, M., P, D., M, E., & S, L. (2018). Targeting Inflammation With Nanosized Drug Delivery Platforms in Cardiovascular Diseases: Immune Cell Modulation in Atherosclerosis.. Frontiers in bioengineering and biotechnology. https://doi.org/10.3389/fbioe.2018.00177
Source records
- pubmed · retrieved 2026-09-25T03:26:05.488Z